Mebamin 50 mg
Mebhydrolin
Category: Tablet
Manufacturer: Square Pharmaceuticals PLC, Pabna
Square Pharmaceuticals PLC, Pabna
Allopathic
MFG. Licence No. Biological
033
MFG. Licence No. Non-Biological
114
Address
Salgaria, Pabna Salgaria, Pabna
Price: 2.01 ৳
5 x 10 in Blister Pack
Medicine Selling service is not available yet.
Related Medicines
Allergic conditions
Premature infants and neonates. Acute asthmatic attack.
Administration:
Should be taken with food. Take during or shortly after meals.
Adult Dose:
Oral
Allergic conditions
Adult: 100-300 mg/day.
Child Dose:
Oral
Allergic conditions
Child: <2 yr: 50-100 mg/day;
2-5 yr: 50-150 mg/day;
5-10 yr: 100-200 mg/day;
>10 yr: 100-300 mg/day.
Enhanced sedation with alcohol or other CNS depressants. Additive antimuscarinic effects with MAOIs, atropine, TCAs. May mask warning symptoms caused by ototoxic agents e.g. aminoglycoside antibiotics.
Premature infants and neonates. Acute asthmatic attack.
CNS depression; paradoxical stimulation (high doses, children or elderly); headache, psychomotor impairment; dry mouth, thickened respiratory tract secretions, blurred vision; urinary difficulty or retention, constipation, increased gastric reflux; nausea, vomiting, diarrhoea, epigastric pain. Rarely, blood disorders. Convulsions, sweating, myalgia, paraesthesias, extrapyramidal effects, tremor, sleep disturbances, depression, confusion, tinnitus, hypotension, hair loss.
Potentially Fatal: Anaphylaxis.
Precaution:
Closed-angle glaucoma; urinary retention, prostatic hyperplasia or pyloroduodenal obstruction; epilepsy. Elderly. Pregnancy. May impair ability to drive or operate machinery.
Mebhydrolin is an ethylenediamine derivative antihistamine with antimuscarinic and sedative properties.
Samm Care